Cardiovascular clinical trials try to demonstrate the benefit of a medication on populations where the number of participants with the targeted disease is very low. The low efficacy of treatment is partially due to the diversity of diseases and of the population. To improve the efficacy of treatment, it is necessary to improve the recruitment […]
Read More